• No results found

Title: Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer

N/A
N/A
Protected

Academic year: 2021

Share "Title: Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer "

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle https://hdl.handle.net/1887/3160747 holds various files of this Leiden University dissertation.

Author: Zunder, S.M.

Title: Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer

Issue Date:

2021-04-15

(2)

Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer

Stéphanie Marleen Zunder

(3)

COLOPHON

Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer by Stéphanie Zunder

ISBN: 978-94-6416-207-3

Cover design and lay-out: Elisa Calamita, persoonlijkproefschrift.nl Printing: Ridderprint | www.ridderprint.nl

© S.M. Zunder, 2021, Leiden, The Netherlands

All rights reserved. No part of this thesis may be reproduced or transmitted in any form, by any means, electronic or mechanical without prior permission of the author.

Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer

Proefschrift

ter verkrijging van

de graad van doctor aan de Universiteit Leiden, op gezag van rector magnificus prof.dr.ir. H. Bijl,

volgens besluit van het college voor promoties te verdedigen op donderdag 15 april 2021

klokke 10.00 uur

door

Stéphanie Marleen Zunder geboren te Willemstad (Curaçao)

in 1987

(4)

Exploring prognostic and predictive application of the tumor-stroma ratio in colorectal cancer

Proefschrift

ter verkrijging van

de graad van doctor aan de Universiteit Leiden, op gezag van rector magnificus prof.dr.ir. H. Bijl,

volgens besluit van het college voor promoties te verdedigen op donderdag 15 april 2021

klokke 10.00 uur

door

Stéphanie Marleen Zunder geboren te Willemstad (Curaçao)

in 1987

(5)

Promotores

Prof. dr. A. J. Gelderblom Prof. dr. R.A.E.M. Tollenaar Co-promoter

Dr. W.E. Mesker Promotiecommissie Prof. dr. J.E.A. Portielje

Prof. dr. G.L. Beets (Antoni van Leeuwenhoek, NKI, Amsterdam) Prof. dr. J.H.J.M. van Krieken (Radboud Universiteit, Nijmegen)

(6)

TABLE OF CONTENTS Chapter 1

General introduction and outline 7

Chapter 2

The significance of stromal collagen organization in cancer tissue: an in-depth discussion of literature

Critical Reviews in Oncology Hematology 2020 Jul;151:102907

19

Chapter 3

Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial Cellular Oncology 2019 Oct;42(5):717-725

61

Chapter 4

Predictive potential of tumor-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer British Journal of Cancer 2018 Jul;119(2):164-169

83

Chapter 5

Prognostic and predictive value of tumor-stroma ratio in stage II colorectal cancer

107

Clinal Oncology and Research 2020 Apr;3(4): 3-8 Chapter 6

Correlation of the tumor-stroma ratio with diffusion weighted MRI in rectal cancer

125

European Journal of Radiology 2020, Oct:109345 Chapter 7

Summary, general discussion and future perspectives 143

Chapter 8 153

Nederlandse samenvatting Appendices

List of publications, author affiliations, curriculum vitae, dankwoord 161

(7)

Referenties

GERELATEERDE DOCUMENTEN

We will assess if the TSR provides predictive information, which could serve as a marker for adjuvant therapy in this group and validate the prognostic power of the

Prognostic value of the immune status of tumors The immune status of tumors was classified as high in 18.9%, intermediate in 63.1% and low in 18.0% of the breast cancer cases..

Expl oring pr ognostic and pr ed icti ve applica tio n of the tumo r-str oma ra tio in col orectal cance r

The stroma percentage has to be determined from only the solid (= neoplastic + vital stromal compartment) tissue parts.. cells) should be replaced by another area for scoring, or,

cancer: final results for first-line treatment from the ITACa randomized clinical trial. Annals

Part II: Prognostic and predictive aspects of the tumor-associated stroma in breast cancer The prognostic role of TGF-β signaling pathway in breast cancer patients Annals of

The retrospective patient cohort consisted of consecutive patients with esophageal cancer clinical stage I–III with adenocar- cinoma or squamous cell carcinoma, who

a/b Co-injection of fibroblasts with SMAD4-deficient HT29 cells ( n = 5) increased liver metastatic outgrowth. c Confirmation of liver metastatic lesions ex vivo. d/e/f Co- injection